Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
European Radiology
Published in: European Radiology 11/2007

01-11-2007 | Magnetic Resonance

Perspectives for preventive screening with total body MRI

Authors: Susanne C. Ladd, Mark E. Ladd

Published in: European Radiology | Issue 11/2007

Login to get access

Abstract

Radiology has started to increasingly recognise its potential for screening with the advent of “whole-body” imaging techniques. This article briefly reviews prerequisites for successful screening, presents a quick summary of single-organ screening with magnetic resonance (MR) imaging, and introduces how this knowledge can be integrated into whole-body MR (wb-MR) screening. MR colonography has demonstrated its potential for screening. Wb-MR in the form of wb-MR angiography has already entered both clinical and screening settings; also, the search for metastases with wb-MR has been evaluated and has performed well when compared with other imaging modalities. But screening a group of healthy subjects requires more than feasibility and high accuracy of the screening test; thus, technical and ethical considerations are also presented. Wb-MR is only at its beginning and will in the near future certainly inspire many new research activities as well as transform the radiological market.
Literature
1.
Haustein J, Laniado M, Niendorf HP et al (1993) Triple-dose versus standard-dose gadopentetate dimeglumine: a randomized study in 199 patients. Radiology 186:855–860PubMed
2.
Haustein J, Niendorf HP, Krestin G et al (1992) Renal tolerance of gadolinium-DTPA/dimeglumine in patients with chronic renal failure. Invest Radiol 27:153–156PubMedCrossRef
3.
Hirai T, Korogi Y, Ono K et al (2002) Prospective evaluation of suspected stenoocclusive disease of the intracranial artery: combined MR angiography and CT angiography compared with digital subtraction angiography. AJNR Am J Neuroradiol 23:93–101PubMed
4.
Korst MB, Joosten FB, Postma CT, Jager GJ, Krabbe JK, Barentsz JO (2000) Accuracy of normal-dose contrast-enhanced MR angiography in assessing renal artery stenosis and accessory renal arteries. AJR Am J Roentgenol 174:629–634PubMed
5.
Hany TF, Debatin JF, Leung DA, Pfammatter T (1997) Evaluation of the aortoiliac and renal arteries: comparison of breath-hold, contrast-enhanced, three-dimensional MR angiography with conventional catheter angiography. Radiology 204:357–362PubMed
6.
Goyen M, Quick HH, Debatin JF et al (2002) Whole body 3D MR angiography using a rolling table platform: initial clinical experience. Radiology 224:270–277PubMedCrossRef
7.
Hawighorst H, Schoenberg SO, Knopp MV, Essig M, Miltner P, van Kaick G (1999) Hepatic lesions: morphologic and functional characterization with multiphase breath-hold 3D gadolinium-enhanced MR angiography—initial results. Radiology 210:89–96PubMed
8.
Kramer H, Schoenberg SO, Nikolaou K et al (2005) Cardiovascular screening with parallel imaging techniques and a whole-body MR imager. Radiology 236:300–310PubMedCrossRef
9.
Bayes T (1763) An essay towards solving a problem in the doctrine of chances. Philos Trans R Soc Lond 53:370–418CrossRef
10.
La Veccia C, Luccini F, Negri E, Boyle P, Maisonneuve P, Levi F (1992) Trends in cancer mortality in Europe, 1955–1989: III, Breast and genital sites. Eur J Cancer 28:927–998CrossRef
11.
Neuhaus H (1999) Screening for colorectal cancer in Germany: guidelines and reality. Endoscopy 31:468–470PubMedCrossRef
12.
Villavicencio RT, Rex DX (2000) Colonic adenomas: prevalence and incidence rates, growth rates, and miss rates at colonoscopy. Semin Gastrointest Dis 11:185–193PubMed
13.
Chambless L, Keil U, Dobson A et al (1997) Population versus clinical view of case fatality from acute coronary heart disease—results from the WHO Monica project 1985–1990. Circulation 96:3849–3859PubMed
14.
Fuster V, Pearson TA (1996) 27th Bethesda Conference. Matching the intensity of risk factor mangement with the hazard for coronary heart disease events. J Am Coll Cardiol 27:957–1047CrossRef
15.
16.
17.
European guidelines for screening mammography, August 1997 edition (EUREF). European Commission, Brussels Luxembourg
18.
Strax P, Venet L, Shapiro S et al (1967) Mammography and clinical examination in mass screening for cancer of the breast. Cancer 20:2184–2188PubMedCrossRef
19.
Ahmed S, Shellock FG (2001) Magnetic resonance imaging safety: implications for cardiovascular patients. J Cardiovasc Magn Reson 3:171–182PubMedCrossRef
20.
Prince MR, Arnoldus C, Frisoli JK (1996) Nephrotoxicity of high-dose gadolinium compared with iodinated contrast. J Magn Reson Imaging 6:162–166PubMedCrossRef
21.
Shellock FG, Kanal E (1999) Safety of magnetic resonance imaging contrast agents. J Magn Reson Imaging 10:477–484PubMedCrossRef
22.
Nederkoorn PJ, Mali WP, Eikelboom BC et al (2002) Preoperative diagnosis of carotid artery stenosis: accuracy of noninvasive testing. Stroke 33:2003–2008PubMedCrossRef
23.
Korst MB, Joosten FB, Postma CT, Jager GJ, Krabbe JK, Barentsz JO (2000) Accuracy of normal-dose contrast-enhanced MR angiography in assessing renal artery stenosis and accessory renal arteries. AJR Am J Roentgenol 174:629–634PubMed
24.
Goyen M, Quick HH, Debatin JF et al (2002) Whole body 3D MR angiography using a rolling table platform: initial clinical experience. Radiology 224:270–277PubMedCrossRef
25.
Hany TF, Debatin JF, Leung DA, Pfammatter T (1997) Evaluation of the aortoiliac and renal arteries: comparison of breath-hold, contrast-enhanced, three-dimensional MR angiography with conventional catheter angiography. Radiology 204:357–362PubMed
26.
Van der Geest RJ, Reiber JHC (1999) Quantification in cardiac MRI. J Magn Reson Imaging 10:602–608PubMedCrossRef
27.
Barkhausen J, Ruehm SG, Goyen M, Buck T, Laub G, Debatin JF (2001) MR evaluation of ventricular function: true fast imaging with steady-state precession versus fast low-angle shot cine MR imaging: feasibility study. Radiology 219:264–269PubMed
28.
Hunold P, Brandt-Mainz K, Freudenberg L et al (2002) Evaluation of myocardial viability with contrast-enhanced magnetic resonance imaging-comparison of the late enhancement technique with positronemission tomography. Rofo 174:867–873PubMed
29.
Klein C, Nekolla SG, Bengel FM et al (2002) Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging: comparison with positron emission tomography. Circulation 105:162–167PubMedCrossRef
30.
Lundblad D, Eliasson M (2003) Silent myocardial infarction in women with impaired glucose tolerance: the Northern Sweden MONICA study. Cardiovasc Diabetol 2:9PubMedCrossRef
31.
Hirai T, Korogi Y, Ono K et al (2002) Prospective evaluation of suspected stenoocclusive disease of the intracranial artery: combined MR angiography and CT angiography compared with digital subtraction angiography. AJNR Am J Neuroradiol 23:93–101PubMed
32.
Kim DE, Bae HJ, Lee SH, Kim H, Yoon BW, Roh JK (2002) Gradient echo magnetic resonance imaging in the prediction of hemorrhagic vs ischemic stroke: a need for the consideration of the extent of leukoariosis. Arch Neurol 59:425–429PubMedCrossRef
33.
Wong TY, Klein R, Sharrett AR et al (2002) Cerebral white matter lesions, retinopathy, and incident clinical stroke. JAMA 288:67–74PubMedCrossRef
34.
Vermeer SE, Hollander M, van Dijk EJ (2003) Silent brain infarcts and white matter lesions increase stroke risk in the general population. Stroke 34:1126–1129PubMedCrossRef
35.
Starr JM, Leaper SA, Murray AD et al (2003) Brain white matter lesions detected by magnetic resonance [correction of resosnance] imaging are associated with balance and gait speed. Neurol Neurosurg Psychiatry 74:94–98CrossRef
36.
Herskovits EH, Itoh R, Melhem ER (2001) Accuracy for detection of simulated lesions: comparison of fluid-attenuated inversion-recovery, proton density-weighted, and T2-weighted synthetic brain MR imaging. AJR Am J Roentgenol 176:1313–1318PubMed
37.
Heywang SH, Wolf A, Pruss E et al (1989) MR imaging of the breast with Gd-DTPA: use and limitations. Radiology 171:95–103PubMed
38.
Leach MO, Boggis CR, Dixon AK et al (2005) Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS). Lancet 365:1769–1778PubMedCrossRef
39.
Kawashima H, Matsui O, Suzuki M et al (2000) Breast cancer in dense breast: detection with contrast-enhanced dynamic MR imaging. J Magn Reson Imaging 11:233–243PubMedCrossRef
40.
Herborn CU, Marincek B, Erfmann D et al (2002) Breast augmentation and reconstructive surgery: MR imaging of implant rupture and malignancy. Eur Radiol 12:2198–2206PubMed
41.
Ikonen S, Kivisaari L, Tervahartiala P, Vehmas T, Taari K, Rannikko S (2001) Prostatic MR imaging. Accuracy in differentiating cancer from other prostatic disorders. Acta Radiol 42:348–354PubMed
42.
Mueller-Lisse UG, Scherr M (2003) [1H magnetic resonance spectroscopy of the prostate.] Radiologe 43:481–488PubMedCrossRef
43.
Cornud F, Flam T, Chauveinc L et al (2002) Extraprostatic spread of clinically localized prostate cancer: factors predictive of pT3 tumor and of positive endorectal MR imaging examination results. Radiology 224:203–210PubMedCrossRef
44.
Luboldt W, Bauerfeind P, Wildermuth S, Marincek B, Fried M, Debatin JF (2000) Colonic masses: detection with MR colonography. Radiology 216:383–388PubMed
45.
Lauenstein TC, Debatin JF (2001) Magnetic resonance colonography for colorectal cancer screening. Semin Ultrasound CT MR 22:443–453PubMedCrossRef
46.
Villavicencio RT, Rex DX (2000) Colonic adenomas: prevalence and incidence rates, growth rates, and miss rates at colonoscopy. Semin Gastrointest Dis 11:185–193PubMed
47.
Hartmann D, Bassler B, Pfeifer B et al (2006) Patient acceptance of magnetic resonance colonography: a prospective inquiry for comparison to conventional colonoscopy. Dtsch Med Wochenschr 131:2519–2523PubMedCrossRef
48.
Li F, Sone S, Maruyama Y et al (2000) Correlation between high-resolution computed tomographic, magnetic resonance and pathological findings in cases with non-cancerous but suspicious lung nodules. Eur Radiol 10:1782–1791PubMedCrossRef
49.
Thompson BH, Stanford W (2000) MR imaging of pulmonary and mediastinal malignancies. Magn Reson Imaging Clin N Am 8:729–739PubMed
50.
Schroeder T, Ruehm SG, Debatin JF, Ladd ME, Barkhausen J, Goehde SC (2005) Detection of pulmonary nodules using a 2D HASTE MR sequence: comparison with MDCT. AJR Am J Roentgenol 185:979–984PubMedCrossRef
51.
Erturan S, Yaman M, Aydin G, Uzel I, Musellim B, Kaynak K (2005) The role of whole-body bone scanning and clinical factors in detecting bone metastases in patients with non-small cell lung cancer. Chest 127:449–454PubMedCrossRef
52.
Steinborn MM, Heuck AF, Tiling R, Bruegel M, Gauger L, Reiser MF (1999) Whole-body bone marrow MRI in patients with metastatic disease to the skeletal system. J Comput Assist Tomogr 23:123–129PubMedCrossRef
53.
Ruehm SG, Goyen M, Quick HH et al (2000) [Whole-body MRA on a rolling table platform (AngioSURF).] Rofo 172:670–674PubMed
54.
Li W, Vu AT, Tutton S et al (2006) Scoutless stepping-table peripheral contrast-enhanced MR angiography. J Magn Reson Imaging 23:235–241PubMedCrossRef
55.
Quick HH, Vogt FM, Maderwald S et al (2004) [High spatial resolution whole-body MR angiography featuring parallel imaging: initial experience.] Rofo 176:163–169PubMed
56.
Gohde SC, Goyen M, Forsting M, Debatin JF (2002) [Prevention without radiation—a strategy for comprehensive early detection using magnetic resonance tomography.] Radiologe 42:622–629PubMedCrossRef
57.
Fenchel M, Scheule AM, Stauder NI et al (2006) Atherosclerotic disease: whole-body cardiovascular imaging with MR system with 32 receiver channels and total-body surface coil technology—initial clinical results. Radiology 238:280–291PubMedCrossRef
58.
Steinborn MM, Heuck AF, Tiling R, Bruegel M, Gauger L, Reiser MF (1999) Whole-body bone marrow MRI in patients with metastatic disease to the skeletal system. J Comput Assist Tomogr 23:123–129PubMedCrossRef
59.
Eustace S, Tello R, DeCarvalho V et al (1997) A comparison of whole-body turboSTIR MR imaging and planar 99mTc-methylene diphosphonate scintigraphy in the examination of patients with suspected skeletal metastases. AJR Am J Roentgenol 169:1655–1661PubMed
60.
Walker R, Kessar P, Blanchard R et al (2000) Turbo STIR magnetic resonance imaging as a whole-body screening tool for metastases in patients with breast carcinoma: preliminary clinical experience. J Magn Reson Imaging 11:343–350PubMedCrossRef
61.
Antoch G, Vogt FM, Freudenberg LS et al (2003) Whole-body dual-modality PET/CT and whole body MRI for tumor staging in oncology. JAMA 290:3199–3206PubMedCrossRef
62.
Lauenstein TC, Goehde SC, Herborn CU et al (2002) Three-dimensional volumetric interpolated breath-hold MR imaging for whole-body tumor staging in less than 15 minutes: a feasibility study. AJR Am J Roentgenol 179:445–449PubMed
63.
Schmidt GP, Baur-Melnyk A, Herzog P (2005) High-resolution whole-body magnetic resonance image tumor staging with the use of parallel imaging versus dual-modality positron emission tomography-computed tomography: experience on a 32-channel system. Invest Radiol 40:743–753PubMedCrossRef
64.
Lauenstein TC, Freudenberg LS, Goehde SC et al (2002) Whole-body MRI using a rolling table platform for the detection of bone metastases. Eur Radiol 12:2091–2099PubMed
65.
Ghanem N, Altehoefer C, Hogerle S et al (2002) Comparative diagnostic value and therapeutic relevance of magnetic resonance imaging and bone marrow scintigraphy in patients with metastatic solid tumors of the axial sceleton. Eur J Radiol 43:256–261PubMedCrossRef
66.
Schlemmer HP, Schafer J, Pfannenberg C et al (2005) Fast whole-body assessment of metastatic disease using a novel magnetic resonance imaging system: initial experiments. Invest Radiol 40:64–71PubMedCrossRef
67.
Fenchel M, Jost D, Kramer U et al (2006) [Cardiovascular whole-body MR imaging in patients with symptomatic peripheral arterial occlusive disease.] Rofo 178:491–499PubMed
68.
Ladd SC, Debatin JF, Stang A et al (2007) Whole-body MR vascular screening detects unsuspected concomitant vascular disease in coronary heart disease patients. Eur Radiol 17:1035–1045PubMedCrossRef
69.
Preamble to the Constitution of the World Health Organization as adopted by the International Health Conference, New York, 19–22 June, 1946; signed on 22 July 1946 by the representatives of 61 States (Official Records of the World Health Organization, no. 2, p. 100) and entered into force on 7 April 1948
70.
Leiner T, de Vries M, Hoogeveen R, Vasbinder GB, Lemaire E, van Engelshoven JM (2003) Contrast-enhanced peripheral MR angiography at 3.0 Tesla: initial experience with a whole-body scanner in healthy volunteers. J Magn Reson Imaging 17:609–614PubMedCrossRef
71.
Kruger DG, Riederer SJ, Grimm RC, Rossman PJ (2002) Continuously moving table data acquisition method for long FOV contrast-enhanced MRA and whole-body MRI. Magn Reson Med 47:224–231PubMedCrossRef
72.
Zenge MO, Ladd ME, Vogt FM, Brauck K, Barkhausen J, Quick HH (2005) Whole-body magnetic resonance imaging featuring moving table continuous data acquisition with high-precision position feedback. Magn Reson Med 54:707–711PubMedCrossRef
73.
Shankaranarayanan A, Herfkens R, Hargreaves BM, Polzin JA, Santos JM, Brittain JH (2003) Helical MR: continuously moving table axial imaging with radial acquisitions. Magn Reson Med 50:1053–1060PubMedCrossRef
74.
Keupp J, Aldefeld B, Bornert P (2005) Continuously moving table SENSE imaging. Magn Reson Med 53:217–220PubMedCrossRef
75.
Gaa J, Rummeny EJ, Seemann MD (2004) Whole-body imaging with PET/MRI. Eur J Med Res 30:309–312
Metadata
Title
Perspectives for preventive screening with total body MRI
Authors
Susanne C. Ladd
Mark E. Ladd
Publication date
01-11-2007
Publisher
Springer-Verlag
Published in
European Radiology / Issue 11/2007
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-007-0657-3

Other articles of this Issue 11/2007

European Radiology 11/2007 Go to the issue

Cardiac

Accuracy of contrast-enhanced cine-MR sequences in the assessment of left ventricular function: comparison with precontrast cine-MR sequences. Results of a bicentric study

Experimental

Sixty-four-slice CT in the assessment of global and regional left ventricular function: Comparison with MRI in a porcine model of acute and subacute myocardial infarction

Interpretation Corner

Calvarial tuberculosis: an unusual presentation (2007: 8b)

Urogenital

MRI of the kidney—state of the art

Computer Tomography

Flat-detector computed tomography (FD-CT)

Cardiac

Coronary fly-through or virtual angioscopy using dual-source MDCT data